Status:
NOT_YET_RECRUITING
Kentucky Women's Justice Community Overdose Innovation Network - Phase II
Lead Sponsor:
Michele Staton
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Overdose Risk
Opioid Use Disorder
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transiti...
Detailed Description
Overdose deaths among women rose nearly 500% in the past two decades, a rate considerably higher than men. Yet, overdose prevention approaches that target the unique risks of women, particularly those...
Eligibility Criteria
Inclusion
- DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD),
- no evidence of cognitive impairment in providing consent,
- a release date within 7-60 days to allow for time for intervention sessions,
- willingness to consider SUD treatment post-release, and
- willingness to provide the name and contact information of at least one person in the community who will support the woman's recovery pre/post-release (SP).
Exclusion
- Not living in a rural area
- Any condition that would not allow capable informed consent
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07179614
Start Date
February 1 2026
End Date
October 30 2030
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40506